Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/20/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Alistair G. Draffan

Wrong Dr. Alistair G. Draffan?

Phone: +61 *********  
Local Address:  Australia
Biota Pharmaceuticals Inc
2500 Northwinds Parkway Suite 100
Alpharetta , Georgia 30009
United States

Company Description: Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat a number of...   more

Employment History


  • BSc
  • PhD , organic chemistry
    University of Nottingham , UK
6 Total References
Web References
Alistair G. Draffan has more ..., 20 Nov 2015 [cached]
Alistair G. Draffan has more than 15 years' pharmaceutical industry experience in the discovery, development and commercialisation of novel drugs. Alistair was Director, Drug Discovery at Biota with responsibility for managing a multidisciplinary group of expert scientists, defining research and IP strategies and ensuring that collaborative R&D was executed to the highest standards. He has led teams working on numerous anti-infective projects including those that successfully identified antiviral candidates for RSV and hepatitis C (nucleosides and non-nucleosides). Alistair worked as a Senior Medicinal Chemist at Celltech R&D (UCB Pharma, UK) before joining Biota in 2002 and holds a PhD in organic chemistry from the University of Nottingham, UK and a BSc (Hons) degree in chemistry from the University of Glasgow, UK.
Bioactive Discovery & Development Group - The Royal Australian Chemical Institute Incorporated, 8 Dec 2010 [cached]
Dr Alistair Draffan Director, Drug Discovery, Biota
Ausbiotech 2010 National Conference - Speakers, 14 Oct 2010 [cached]
Dr Alistair Draffan, Director Drug Discovery, Biota Holdings Limited
Biota Pharmaceuticals Incorporated: Scientific Publications & Presentations [cached]
"Discovery of a New Series of Pan-genotypic NS5b Inhibitors for Hepatitis C: the Indazole Amide Class of Site IV Polymerase Antivirals", presented by Dr Alistair Draffan, Director, Drug Discovery. 
Biota Holdings Limited: Scientific Publications & Presentations, 1 Oct 2009 [cached]
"Discovery of new orally active antivirals for the treatment of Respiratory Syncytial Virus (RSV): identification of a clinical candidate", presented by Dr Alistair Draffan, Director, Drug Discovery.
"Discovery of a new class of Inhibitors for Respiratory Syncytial Virus (RSV)" presented by Dr Alistair Draffan, Director, Drug Discovery. 8 October 2008: University of Adelaide, Australia.
 July 2008
"Discovery of a new class of polycyclic RSV inhibitors" presented by Dr Alistair Draffan, Director, Drug Discovery.
"Discovery of a new class of polycyclic RSV inhibitors" and "Preclinical development of a new class of orally active drug candidates for the treatment of RSV infections" presented by Dr Alistair Draffan, Associate Director, Medicinal Chemistry.
Other People with the name "Draffan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.